Comparison of methods using paraffin-embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution

Yutaka Torii, Takuma Fujii, Iwao Kukimoto, Miyuki Saito, Takashi Iwata, Hiroshi Takahashi, Ryoko Ichikawa, Satoshi Kawai, Sayaka Otani, Daisuke Aoki

Research output: Contribution to journalArticle

Abstract

Monitoring the attribution of human papillomavirus (HPV) genotypes to cervical precancerous lesions is essential in assessing the efficacy of HPV vaccines. To resolve the lack of studies comparing the HPV genotyping procedures used to estimate HPV genotype attribution, we undertook a retrospective cross-sectional study to determine the appropriate genotyping procedures for evaluating the potential efficacy of HPV vaccines. Three procedures, including two different genotyping methods, Clinichip HPV test (C-Chip) and modified GP5+/6+ PCR coupled to fluorescent bead sorter detection (MGP), using exfoliated cervical cells (C-Chip and C-MGP, respectively) or formalin-fixed paraffin-embedded tissues (F-MGP), were compared. The overall agreement in detecting high-risk HPV was 88.5–92.1% among the three procedures, and genotype-specific agreement was 83.9–100% for all pairwise comparisons. In cervical intraepithelial neoplasia grade 2/3 specimens, HPV16/18 attribution estimated with the hierarchical attribution method was consistent among the procedures: 52.3% (45/86) for C-Chip, 54.7% (47/86) for C-MGP, and 52.3% (45/86) for F-MGP (P = 0.81). HPV16/18/31/33/45/52/58 hierarchical attribution was 88.4% (76/86) with C-Chip, 86.0% (74/86) with C-MGP, and 83.7% (72/86) with F-MGP (P = 0.49). In cervical intraepithelial neoplasia grade 3 specimens, the corresponding hierarchical attribution was 96.4% (53/55) with C-Chip, 89.1% (49/55) with C-MGP, and 94.5% (52/55) with F-MGP (P = 0.27). Although F-MGP is theoretically a reliable method for determining HPV genotype attribution, it is acceptable to use C-Chip or C-MGP, coupled to the hierarchical attribution formula to correct the bias of multiple infections. These approaches using exfoliated cervical cells are practical for monitoring the efficacy of HPV vaccines.

Original languageEnglish
Pages (from-to)1520-1526
Number of pages7
JournalCancer Science
Volume107
Issue number10
DOIs
Publication statusPublished - 01-10-2016

Fingerprint

Paraffin
Genotype
Papillomavirus Vaccines
Cervical Intraepithelial Neoplasia
Formaldehyde
Cross-Sectional Studies
Polymerase Chain Reaction
Infection

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Torii, Yutaka ; Fujii, Takuma ; Kukimoto, Iwao ; Saito, Miyuki ; Iwata, Takashi ; Takahashi, Hiroshi ; Ichikawa, Ryoko ; Kawai, Satoshi ; Otani, Sayaka ; Aoki, Daisuke. / Comparison of methods using paraffin-embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution. In: Cancer Science. 2016 ; Vol. 107, No. 10. pp. 1520-1526.
@article{40e93a1f013b4c859384ff8154ff159f,
title = "Comparison of methods using paraffin-embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution",
abstract = "Monitoring the attribution of human papillomavirus (HPV) genotypes to cervical precancerous lesions is essential in assessing the efficacy of HPV vaccines. To resolve the lack of studies comparing the HPV genotyping procedures used to estimate HPV genotype attribution, we undertook a retrospective cross-sectional study to determine the appropriate genotyping procedures for evaluating the potential efficacy of HPV vaccines. Three procedures, including two different genotyping methods, Clinichip HPV test (C-Chip) and modified GP5+/6+ PCR coupled to fluorescent bead sorter detection (MGP), using exfoliated cervical cells (C-Chip and C-MGP, respectively) or formalin-fixed paraffin-embedded tissues (F-MGP), were compared. The overall agreement in detecting high-risk HPV was 88.5–92.1{\%} among the three procedures, and genotype-specific agreement was 83.9–100{\%} for all pairwise comparisons. In cervical intraepithelial neoplasia grade 2/3 specimens, HPV16/18 attribution estimated with the hierarchical attribution method was consistent among the procedures: 52.3{\%} (45/86) for C-Chip, 54.7{\%} (47/86) for C-MGP, and 52.3{\%} (45/86) for F-MGP (P = 0.81). HPV16/18/31/33/45/52/58 hierarchical attribution was 88.4{\%} (76/86) with C-Chip, 86.0{\%} (74/86) with C-MGP, and 83.7{\%} (72/86) with F-MGP (P = 0.49). In cervical intraepithelial neoplasia grade 3 specimens, the corresponding hierarchical attribution was 96.4{\%} (53/55) with C-Chip, 89.1{\%} (49/55) with C-MGP, and 94.5{\%} (52/55) with F-MGP (P = 0.27). Although F-MGP is theoretically a reliable method for determining HPV genotype attribution, it is acceptable to use C-Chip or C-MGP, coupled to the hierarchical attribution formula to correct the bias of multiple infections. These approaches using exfoliated cervical cells are practical for monitoring the efficacy of HPV vaccines.",
author = "Yutaka Torii and Takuma Fujii and Iwao Kukimoto and Miyuki Saito and Takashi Iwata and Hiroshi Takahashi and Ryoko Ichikawa and Satoshi Kawai and Sayaka Otani and Daisuke Aoki",
year = "2016",
month = "10",
day = "1",
doi = "10.1111/cas.13030",
language = "English",
volume = "107",
pages = "1520--1526",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "10",

}

Comparison of methods using paraffin-embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution. / Torii, Yutaka; Fujii, Takuma; Kukimoto, Iwao; Saito, Miyuki; Iwata, Takashi; Takahashi, Hiroshi; Ichikawa, Ryoko; Kawai, Satoshi; Otani, Sayaka; Aoki, Daisuke.

In: Cancer Science, Vol. 107, No. 10, 01.10.2016, p. 1520-1526.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of methods using paraffin-embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution

AU - Torii, Yutaka

AU - Fujii, Takuma

AU - Kukimoto, Iwao

AU - Saito, Miyuki

AU - Iwata, Takashi

AU - Takahashi, Hiroshi

AU - Ichikawa, Ryoko

AU - Kawai, Satoshi

AU - Otani, Sayaka

AU - Aoki, Daisuke

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Monitoring the attribution of human papillomavirus (HPV) genotypes to cervical precancerous lesions is essential in assessing the efficacy of HPV vaccines. To resolve the lack of studies comparing the HPV genotyping procedures used to estimate HPV genotype attribution, we undertook a retrospective cross-sectional study to determine the appropriate genotyping procedures for evaluating the potential efficacy of HPV vaccines. Three procedures, including two different genotyping methods, Clinichip HPV test (C-Chip) and modified GP5+/6+ PCR coupled to fluorescent bead sorter detection (MGP), using exfoliated cervical cells (C-Chip and C-MGP, respectively) or formalin-fixed paraffin-embedded tissues (F-MGP), were compared. The overall agreement in detecting high-risk HPV was 88.5–92.1% among the three procedures, and genotype-specific agreement was 83.9–100% for all pairwise comparisons. In cervical intraepithelial neoplasia grade 2/3 specimens, HPV16/18 attribution estimated with the hierarchical attribution method was consistent among the procedures: 52.3% (45/86) for C-Chip, 54.7% (47/86) for C-MGP, and 52.3% (45/86) for F-MGP (P = 0.81). HPV16/18/31/33/45/52/58 hierarchical attribution was 88.4% (76/86) with C-Chip, 86.0% (74/86) with C-MGP, and 83.7% (72/86) with F-MGP (P = 0.49). In cervical intraepithelial neoplasia grade 3 specimens, the corresponding hierarchical attribution was 96.4% (53/55) with C-Chip, 89.1% (49/55) with C-MGP, and 94.5% (52/55) with F-MGP (P = 0.27). Although F-MGP is theoretically a reliable method for determining HPV genotype attribution, it is acceptable to use C-Chip or C-MGP, coupled to the hierarchical attribution formula to correct the bias of multiple infections. These approaches using exfoliated cervical cells are practical for monitoring the efficacy of HPV vaccines.

AB - Monitoring the attribution of human papillomavirus (HPV) genotypes to cervical precancerous lesions is essential in assessing the efficacy of HPV vaccines. To resolve the lack of studies comparing the HPV genotyping procedures used to estimate HPV genotype attribution, we undertook a retrospective cross-sectional study to determine the appropriate genotyping procedures for evaluating the potential efficacy of HPV vaccines. Three procedures, including two different genotyping methods, Clinichip HPV test (C-Chip) and modified GP5+/6+ PCR coupled to fluorescent bead sorter detection (MGP), using exfoliated cervical cells (C-Chip and C-MGP, respectively) or formalin-fixed paraffin-embedded tissues (F-MGP), were compared. The overall agreement in detecting high-risk HPV was 88.5–92.1% among the three procedures, and genotype-specific agreement was 83.9–100% for all pairwise comparisons. In cervical intraepithelial neoplasia grade 2/3 specimens, HPV16/18 attribution estimated with the hierarchical attribution method was consistent among the procedures: 52.3% (45/86) for C-Chip, 54.7% (47/86) for C-MGP, and 52.3% (45/86) for F-MGP (P = 0.81). HPV16/18/31/33/45/52/58 hierarchical attribution was 88.4% (76/86) with C-Chip, 86.0% (74/86) with C-MGP, and 83.7% (72/86) with F-MGP (P = 0.49). In cervical intraepithelial neoplasia grade 3 specimens, the corresponding hierarchical attribution was 96.4% (53/55) with C-Chip, 89.1% (49/55) with C-MGP, and 94.5% (52/55) with F-MGP (P = 0.27). Although F-MGP is theoretically a reliable method for determining HPV genotype attribution, it is acceptable to use C-Chip or C-MGP, coupled to the hierarchical attribution formula to correct the bias of multiple infections. These approaches using exfoliated cervical cells are practical for monitoring the efficacy of HPV vaccines.

UR - http://www.scopus.com/inward/record.url?scp=84992454910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992454910&partnerID=8YFLogxK

U2 - 10.1111/cas.13030

DO - 10.1111/cas.13030

M3 - Article

C2 - 27501394

AN - SCOPUS:84992454910

VL - 107

SP - 1520

EP - 1526

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 10

ER -